Efficacy and epigenetic interactions of novel DNA hypomethylating agent guadecitabine (SGI-110) in preclinical models of hepatocellular carcinoma.

Jueliger, Simone; Lyons, John; Cannito, Sara; Pata, Illar; Pata, Pille; Shkolnaya, Marianna; Lo Re, Oriana; Peyrou, Marion; Villarroya, Francesc; Pazienza, Valerio; Rappa, Francesca; Cappello, Francesco; Azab, Mohammad; Taverna, Pietro; Vinciguerra, Manlio (2016). Efficacy and epigenetic interactions of novel DNA hypomethylating agent guadecitabine (SGI-110) in preclinical models of hepatocellular carcinoma. Epigenetics, 11 (10), 709−720.15592294.2016.1214781.
ajakirjaartikkel
Jueliger, Simone; Lyons, John; Cannito, Sara; Pata, Illar; Pata, Pille; Shkolnaya, Marianna; Lo Re, Oriana; Peyrou, Marion; Villarroya, Francesc; Pazienza, Valerio; Rappa, Francesca; Cappello, Francesco; Azab, Mohammad; Taverna, Pietro; Vinciguerra, Manlio
  • Inglise
Epigenetics
1559-2308
11
10
2016
709720
Ilmunud
1.1. Teadusartiklid, mis on kajastatud Web of Science andmebaasides Science Citation Index Expanded, Social Sciences Citation Index, Arts & Humanities Citation Index ja/või andmebaasis Scopus (v.a. kogumikud)
WOS

Viited terviktekstile

10.1080/15592294.2016.1214781

Lisainfo

DNA methylation;Decitabine;guadecitabine;hepatocellular carcinoma (HCC);histone macroH2A1;steatohepatitis